Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.49 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.49 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5032223 | 0.97 | CHRM2 (0.79) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL4917450 | 0.97 | CHRM2 (0.79) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL4913672 | 0.97 | CHRM2 (0.79) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL9973111 | 0.91 | MEN1 (0.74) | CHRM2KMT2AMEN1TDP1NPC1 | |
| SCHEMBL14045032 | 0.91 | CHRM2 (0.64) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL842161 | 0.89 | CHRM2 (0.67) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL23709459 | 0.89 | CHRM2 (0.62) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL17791373 | 0.89 | CHRM2 (0.62) | CHRM2KMT2AMEN1TDP1CA12 | |
| SCHEMBL11881942 | 0.88 | CA1 (0.69) | CHRM2KMT2AMEN1CA12CA1 | |
| SCHEMBL6397368 | 0.88 | CHRM2 (0.67) | CHRM2KMT2AMEN1TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4448776-A | Method of using certain substituted aliphatic secondary amines or their salts for easing breathing | BUCHER KARL (CH) | 1984-05-15 | — | — | US | claimed |
| CN-116472318-A | Ground protection system with high dynamic fracture bridging | SIKA技术股份公司 | 2023-07-21 | — | — | CN | disclosed |
| EP-4069418-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2022-10-12 | — | — | EP | disclosed |
| EP-4036141-A1 | ADDUCT OF ALKYLATED DIAMINE AND NOVOLAK EPOXY RESIN | SIKA TECHNOLOGY AG (CH) | 2022-08-03 | — | — | EP | disclosed |
| CN-114746179-A | Method for producing amines on copper catalysts | 巴斯夫欧洲公司 | 2022-07-12 | — | — | CN | disclosed |
| EP-3390483-B1 | ENCAPSULATION | PROCTER & GAMBLE (US) | 2022-05-18 | — | — | EP | disclosed |
| EP-3995549-A1 | SOIL PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | Sika Technology AG (CH) | 2022-05-11 | — | — | EP | disclosed |
| EP-3368207-B1 | ENCAPSULATION | ENCAPSYS LLC (US) | 2021-12-01 | — | — | EP | disclosed |
| US-10864167-B2 | Encapsulation | THE PROCTER & GAMBLE COMPANY (US) | 2020-12-15 | — | — | US | disclosed |
| EP-3390483-A1 | ENCAPSULATION | The Procter and Gamble Company (US) | 2018-10-24 | — | — | EP | disclosed |
| US-20180235893-A1 | ENCAPSULATION | THE PROCTER & GAMBLE COMPANY | 2018-08-23 | — | — | US | disclosed |
| US-9937477-B2 | Encapsulation | WATERTITE PRODUCTS, INC. | 2018-04-10 | — | — | US | disclosed |
| EP-1914254-B1 | Crosslinkers for improving stability of polyurethane foams | EVONIK DEGUSSA GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| WO-2017074995-A1 | ENCAPSULATION | ENCAPSYS, LLC (US) | 2017-05-04 | — | — | WO | disclosed |
| WO-2017074997-A1 | ENCAPSULATION | ENCAPSYS, LLC (US) | 2017-05-04 | — | — | WO | disclosed |
| US-20170113200-A1 | Encapsulation | Encapsys,LLC (US) | 2017-04-27 | — | — | US | disclosed |
| US-8552078-B2 | Non-fugitive tertiary amine catalyst and alkylated polyamine crosslinking additives; aging resistance | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-10-08 | — | — | US | disclosed |
| EP-1914254-A1 | Crosslinkers for improving stability of polyurethane foams | Air Products and Chemicals, Inc. (US) | 2008-04-23 | — | — | EP | disclosed |
| US-20080090922-A1 | Crosslinkers for improving stability of polyurethane foams | EVONIK OPERATIONS GMBH (DE) | 2008-04-17 | — | — | US | disclosed |
| US-4448776-A | Method of using certain substituted aliphatic secondary amines or their salts for easing breathing | BUCHER KARL (CH) | 1984-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180235893-A1 | ENCAPSULATION | ACR, ACMSD, SAMM50 | CHRM2 1120/4885KMT2A 1601/4885MEN1 2236/4885 |
| US-10864167-B2 | Encapsulation | ACR, MPHOSPH6, ACMSD | CHRM2 993/4885KMT2A 1564/4885MEN1 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.